Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat

Overview of attention for article published in Cardiovascular Diabetology, February 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 82 Dimensions

Readers on

mendeley: 91 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 632 followers.

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodelling in the metabolic syndrome https://t.co/Zt76uuU2T8 https://t.co/X6HUOnAZ2J https://t.co/YoUKpnU0L8

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.